SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-059044
Filing Date
2010-11-10
Accepted
2010-11-10 16:10:23
Documents
4
Period of Report
2010-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v201798_8k.htm 8-K 30072
2 v201798_ex99-1.htm EX-99.1 286462
3 GRAPHIC logo.jpg GRAPHIC 6859
4 v201798_ex99-2.htm EX-99.2 121272
  Complete submission text file 0001144204-10-059044.txt   449064
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 101180219
SIC: 2836 Biological Products, (No Diagnostic Substances)